nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—saliva—acquired immunodeficiency syndrome	0.0134	0.0968	CbGeAlD
Octreotide—SSTR4—digestive system—acquired immunodeficiency syndrome	0.0108	0.0781	CbGeAlD
Octreotide—SSTR4—nervous system—acquired immunodeficiency syndrome	0.00833	0.0604	CbGeAlD
Octreotide—SSTR4—central nervous system—acquired immunodeficiency syndrome	0.00802	0.0582	CbGeAlD
Octreotide—SSTR3—nervous system—acquired immunodeficiency syndrome	0.00679	0.0492	CbGeAlD
Octreotide—MPO—endothelium—acquired immunodeficiency syndrome	0.00654	0.0475	CbGeAlD
Octreotide—SSTR3—central nervous system—acquired immunodeficiency syndrome	0.00654	0.0474	CbGeAlD
Octreotide—SSTR4—brain—acquired immunodeficiency syndrome	0.00637	0.0462	CbGeAlD
Octreotide—SSTR2—digestive system—acquired immunodeficiency syndrome	0.0059	0.0428	CbGeAlD
Octreotide—MPO—blood plasma—acquired immunodeficiency syndrome	0.00581	0.0421	CbGeAlD
Octreotide—SSTR1—lung—acquired immunodeficiency syndrome	0.0058	0.042	CbGeAlD
Octreotide—SSTR1—nervous system—acquired immunodeficiency syndrome	0.00537	0.0389	CbGeAlD
Octreotide—SSTR3—brain—acquired immunodeficiency syndrome	0.00519	0.0376	CbGeAlD
Octreotide—SSTR1—central nervous system—acquired immunodeficiency syndrome	0.00517	0.0375	CbGeAlD
Octreotide—SSTR2—nervous system—acquired immunodeficiency syndrome	0.00456	0.0331	CbGeAlD
Octreotide—SSTR2—central nervous system—acquired immunodeficiency syndrome	0.0044	0.0319	CbGeAlD
Octreotide—SSTR1—brain—acquired immunodeficiency syndrome	0.0041	0.0298	CbGeAlD
Octreotide—SSTR2—brain—acquired immunodeficiency syndrome	0.00349	0.0253	CbGeAlD
Octreotide—MPO—skin of body—acquired immunodeficiency syndrome	0.00279	0.0203	CbGeAlD
Octreotide—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00226	0.0164	CbGeAlD
Octreotide—MPO—digestive system—acquired immunodeficiency syndrome	0.00224	0.0162	CbGeAlD
Octreotide—MPO—blood—acquired immunodeficiency syndrome	0.00213	0.0154	CbGeAlD
Octreotide—MPO—bone marrow—acquired immunodeficiency syndrome	0.00206	0.0149	CbGeAlD
Octreotide—MPO—spinal cord—acquired immunodeficiency syndrome	0.00205	0.0149	CbGeAlD
Octreotide—MPO—lung—acquired immunodeficiency syndrome	0.00187	0.0135	CbGeAlD
Octreotide—MPO—nervous system—acquired immunodeficiency syndrome	0.00173	0.0125	CbGeAlD
Octreotide—MPO—central nervous system—acquired immunodeficiency syndrome	0.00166	0.0121	CbGeAlD
Octreotide—MPO—brain—acquired immunodeficiency syndrome	0.00132	0.00958	CbGeAlD
Octreotide—MPO—lymph node—acquired immunodeficiency syndrome	0.00128	0.00926	CbGeAlD
Octreotide—SSTR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000829	0.00258	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000824	0.00256	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000822	0.00256	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00081	0.00252	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00081	0.00252	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000809	0.00252	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000806	0.00251	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000806	0.00251	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000806	0.00251	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000806	0.00251	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0008	0.00249	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000795	0.00248	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000795	0.00248	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000791	0.00246	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00079	0.00246	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000785	0.00245	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000777	0.00242	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000777	0.00242	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000773	0.00241	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000773	0.00241	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000771	0.0024	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000771	0.0024	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000744	0.00232	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000739	0.0023	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000738	0.0023	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000729	0.00227	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000729	0.00227	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000722	0.00225	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000718	0.00224	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000717	0.00223	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000716	0.00223	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.0007	0.00218	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000695	0.00216	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000692	0.00216	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000685	0.00213	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000685	0.00213	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000674	0.0021	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000673	0.00209	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000666	0.00207	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000656	0.00204	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000655	0.00204	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000653	0.00203	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000646	0.00201	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000645	0.00201	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000632	0.00197	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000632	0.00197	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000626	0.00195	CbGpPWpGaD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000618	0.00192	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000616	0.00192	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000614	0.00191	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000614	0.00191	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000614	0.00191	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000613	0.00191	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000605	0.00188	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0006	0.00187	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000591	0.00184	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000588	0.00183	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000588	0.00183	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000588	0.00183	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000585	0.00182	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000582	0.00181	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000575	0.00179	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000571	0.00178	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000566	0.00176	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000561	0.00175	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000555	0.00173	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000555	0.00173	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000552	0.00172	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000548	0.00171	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000545	0.0017	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000544	0.00169	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000542	0.00169	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00053	0.00165	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000522	0.00163	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000522	0.00163	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000522	0.00163	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000521	0.00162	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000521	0.00162	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000521	0.00162	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00052	0.00162	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000512	0.0016	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00051	0.00159	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000506	0.00158	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000497	0.00155	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000489	0.00152	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000487	0.00152	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000482	0.0015	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000482	0.0015	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000481	0.0015	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000471	0.00147	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00047	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000467	0.00146	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000467	0.00146	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000467	0.00145	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000461	0.00144	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000459	0.00143	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000458	0.00143	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000458	0.00143	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000448	0.00139	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000442	0.00138	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000433	0.00135	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000426	0.00133	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000424	0.00132	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000423	0.00132	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000421	0.00131	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000421	0.00131	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000416	0.00129	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000416	0.00129	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000403	0.00126	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000397	0.00124	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000389	0.00121	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00037	0.00115	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000369	0.00115	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000366	0.00114	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000358	0.00111	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000355	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000354	0.0011	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000354	0.0011	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000354	0.0011	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000348	0.00108	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000347	0.00108	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000347	0.00108	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000343	0.00107	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000342	0.00107	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00034	0.00106	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00034	0.00106	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000337	0.00105	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000335	0.00104	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000333	0.00104	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000333	0.00104	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00033	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000321	0.001	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00032	0.000998	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000318	0.000992	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000316	0.000985	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000315	0.000981	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000315	0.000981	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000315	0.000981	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000314	0.000978	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000314	0.000977	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000314	0.000977	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000311	0.00097	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000307	0.000956	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000302	0.00094	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000302	0.00094	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000301	0.000938	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000301	0.000938	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000295	0.000918	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000295	0.000918	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000291	0.000905	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000289	0.000901	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000289	0.000899	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000285	0.000887	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000285	0.000887	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000278	0.000866	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000278	0.000866	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000272	0.000848	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000272	0.000848	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000272	0.000848	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000272	0.000847	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000268	0.000834	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000268	0.000834	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000264	0.000822	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000263	0.000819	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000261	0.000813	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00026	0.000809	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000257	0.0008	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000253	0.000788	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000251	0.000783	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000249	0.000776	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000247	0.00077	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000247	0.00077	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000246	0.000765	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000246	0.000765	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00024	0.000746	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000238	0.00074	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000236	0.000735	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00023	0.000715	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000228	0.00071	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000226	0.000705	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000224	0.000699	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000221	0.000688	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000219	0.000681	CbGpPWpGaD
Octreotide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000404	CcSEcCtD
Octreotide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000403	CcSEcCtD
Octreotide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000403	CcSEcCtD
Octreotide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000403	CcSEcCtD
Octreotide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000403	CcSEcCtD
Octreotide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000401	CcSEcCtD
Octreotide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000401	CcSEcCtD
Octreotide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000401	CcSEcCtD
Octreotide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.0004	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.0004	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000216	0.000672	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000399	CcSEcCtD
Octreotide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000398	CcSEcCtD
Octreotide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000215	0.000398	CcSEcCtD
Octreotide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000398	CcSEcCtD
Octreotide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000398	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.000398	CcSEcCtD
Octreotide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000397	CcSEcCtD
Octreotide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000395	CcSEcCtD
Octreotide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000395	CcSEcCtD
Octreotide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.000395	CcSEcCtD
Octreotide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.000394	CcSEcCtD
Octreotide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000394	CcSEcCtD
Octreotide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000394	CcSEcCtD
Octreotide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000393	CcSEcCtD
Octreotide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000393	CcSEcCtD
Octreotide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000393	CcSEcCtD
Octreotide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000212	0.000392	CcSEcCtD
Octreotide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000392	CcSEcCtD
Octreotide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000392	CcSEcCtD
Octreotide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000211	0.000391	CcSEcCtD
Octreotide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000211	0.000391	CcSEcCtD
Octreotide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00039	CcSEcCtD
Octreotide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00039	CcSEcCtD
Octreotide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000389	CcSEcCtD
Octreotide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000388	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00021	0.000653	CbGpPWpGaD
Octreotide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000388	CcSEcCtD
Octreotide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000388	CcSEcCtD
Octreotide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000388	CcSEcCtD
Octreotide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000386	CcSEcCtD
Octreotide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000386	CcSEcCtD
Octreotide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000208	0.000385	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000385	CcSEcCtD
Octreotide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000384	CcSEcCtD
Octreotide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000383	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000207	0.000645	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000207	0.000645	CbGpPWpGaD
Octreotide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000382	CcSEcCtD
Octreotide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000206	0.000381	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00038	CcSEcCtD
Octreotide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00038	CcSEcCtD
Octreotide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000379	CcSEcCtD
Octreotide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000379	CcSEcCtD
Octreotide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000379	CcSEcCtD
Octreotide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.000379	CcSEcCtD
Octreotide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000379	CcSEcCtD
Octreotide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000378	CcSEcCtD
Octreotide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000204	0.000378	CcSEcCtD
Octreotide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000378	CcSEcCtD
Octreotide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000378	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000204	0.000635	CbGpPWpGaD
Octreotide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000377	CcSEcCtD
Octreotide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000377	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000204	0.000634	CbGpPWpGaD
Octreotide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000376	CcSEcCtD
Octreotide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000376	CcSEcCtD
Octreotide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000376	CcSEcCtD
Octreotide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000375	CcSEcCtD
Octreotide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000375	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000202	0.000629	CbGpPWpGaD
Octreotide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000373	CcSEcCtD
Octreotide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000373	CcSEcCtD
Octreotide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000373	CcSEcCtD
Octreotide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.000373	CcSEcCtD
Octreotide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.000373	CcSEcCtD
Octreotide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000372	CcSEcCtD
Octreotide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000201	0.000372	CcSEcCtD
Octreotide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000372	CcSEcCtD
Octreotide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000371	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000201	0.000625	CbGpPWpGaD
Octreotide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000201	0.000371	CcSEcCtD
Octreotide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00037	CcSEcCtD
Octreotide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00037	CcSEcCtD
Octreotide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00037	CcSEcCtD
Octreotide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000369	CcSEcCtD
Octreotide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000369	CcSEcCtD
Octreotide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000368	CcSEcCtD
Octreotide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000367	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000367	CcSEcCtD
Octreotide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000367	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000198	0.000616	CbGpPWpGaD
Octreotide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000366	CcSEcCtD
Octreotide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000365	CcSEcCtD
Octreotide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000365	CcSEcCtD
Octreotide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000365	CcSEcCtD
Octreotide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000364	CcSEcCtD
Octreotide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.000364	CcSEcCtD
Octreotide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000364	CcSEcCtD
Octreotide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000363	CcSEcCtD
Octreotide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000363	CcSEcCtD
Octreotide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000362	CcSEcCtD
Octreotide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.000361	CcSEcCtD
Octreotide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.000361	CcSEcCtD
Octreotide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000361	CcSEcCtD
Octreotide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00036	CcSEcCtD
Octreotide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000195	0.00036	CcSEcCtD
Octreotide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00036	CcSEcCtD
Octreotide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000195	0.00036	CcSEcCtD
Octreotide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00036	CcSEcCtD
Octreotide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000359	CcSEcCtD
Octreotide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.000359	CcSEcCtD
Octreotide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000194	0.000358	CcSEcCtD
Octreotide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000358	CcSEcCtD
Octreotide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000357	CcSEcCtD
Octreotide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000357	CcSEcCtD
Octreotide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000357	CcSEcCtD
Octreotide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000356	CcSEcCtD
Octreotide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000192	0.000355	CcSEcCtD
Octreotide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000192	0.000355	CcSEcCtD
Octreotide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000354	CcSEcCtD
Octreotide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000354	CcSEcCtD
Octreotide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000354	CcSEcCtD
Octreotide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000191	0.000353	CcSEcCtD
Octreotide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000352	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000352	CcSEcCtD
Octreotide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.000351	CcSEcCtD
Octreotide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000351	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00019	0.000591	CbGpPWpGaD
Octreotide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000349	CcSEcCtD
Octreotide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000349	CcSEcCtD
Octreotide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000348	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000188	0.000586	CbGpPWpGaD
Octreotide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000347	CcSEcCtD
Octreotide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000347	CcSEcCtD
Octreotide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000347	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000187	0.000582	CbGpPWpGaD
Octreotide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000345	CcSEcCtD
Octreotide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000345	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000187	0.000581	CbGpPWpGaD
Octreotide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000344	CcSEcCtD
Octreotide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000344	CcSEcCtD
Octreotide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000344	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000186	0.000579	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000186	0.000579	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000186	0.000579	CbGpPWpGaD
Octreotide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000343	CcSEcCtD
Octreotide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000343	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000185	0.000577	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000341	CcSEcCtD
Octreotide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.00034	CcSEcCtD
Octreotide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000184	0.00034	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000184	0.000573	CbGpPWpGaD
Octreotide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00034	CcSEcCtD
Octreotide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.00034	CcSEcCtD
Octreotide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000184	0.000339	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000184	0.000572	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000339	CcSEcCtD
Octreotide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000338	CcSEcCtD
Octreotide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000336	CcSEcCtD
Octreotide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000336	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000181	0.000564	CbGpPWpGaD
Octreotide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000181	0.000334	CcSEcCtD
Octreotide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000334	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000333	CcSEcCtD
Octreotide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000333	CcSEcCtD
Octreotide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000332	CcSEcCtD
Octreotide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000331	CcSEcCtD
Octreotide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000331	CcSEcCtD
Octreotide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00033	CcSEcCtD
Octreotide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00033	CcSEcCtD
Octreotide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00033	CcSEcCtD
Octreotide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00033	CcSEcCtD
Octreotide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00033	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000178	0.000556	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000178	0.000556	CbGpPWpGaD
Octreotide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000178	0.000328	CcSEcCtD
Octreotide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000327	CcSEcCtD
Octreotide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000327	CcSEcCtD
Octreotide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000323	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000323	CcSEcCtD
Octreotide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000321	CcSEcCtD
Octreotide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000321	CcSEcCtD
Octreotide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000321	CcSEcCtD
Octreotide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.00032	CcSEcCtD
Octreotide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000318	CcSEcCtD
Octreotide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000318	CcSEcCtD
Octreotide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000318	CcSEcCtD
Octreotide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000318	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000172	0.000535	CbGpPWpGaD
Octreotide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000316	CcSEcCtD
Octreotide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000316	CcSEcCtD
Octreotide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000316	CcSEcCtD
Octreotide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000316	CcSEcCtD
Octreotide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000315	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000169	0.000528	CbGpPWpGaD
Octreotide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000313	CcSEcCtD
Octreotide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000313	CcSEcCtD
Octreotide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000313	CcSEcCtD
Octreotide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000312	CcSEcCtD
Octreotide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000311	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000168	0.000524	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000168	0.000524	CbGpPWpGaD
Octreotide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000309	CcSEcCtD
Octreotide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000308	CcSEcCtD
Octreotide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000308	CcSEcCtD
Octreotide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000307	CcSEcCtD
Octreotide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000306	CcSEcCtD
Octreotide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000306	CcSEcCtD
Octreotide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000306	CcSEcCtD
Octreotide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000305	CcSEcCtD
Octreotide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000305	CcSEcCtD
Octreotide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000305	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000165	0.000513	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000304	CcSEcCtD
Octreotide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000303	CcSEcCtD
Octreotide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000303	CcSEcCtD
Octreotide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.0003	CcSEcCtD
Octreotide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.000299	CcSEcCtD
Octreotide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000295	CcSEcCtD
Octreotide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000295	CcSEcCtD
Octreotide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000295	CcSEcCtD
Octreotide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000294	CcSEcCtD
Octreotide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000294	CcSEcCtD
Octreotide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000294	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000158	0.000493	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000158	0.000493	CbGpPWpGaD
Octreotide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000292	CcSEcCtD
Octreotide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000291	CcSEcCtD
Octreotide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000291	CcSEcCtD
Octreotide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00029	CcSEcCtD
Octreotide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000289	CcSEcCtD
Octreotide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000289	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000155	0.000484	CbGpPWpGaD
Octreotide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000286	CcSEcCtD
Octreotide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000284	CcSEcCtD
Octreotide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000282	CcSEcCtD
Octreotide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00028	CcSEcCtD
Octreotide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00028	CcSEcCtD
Octreotide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000277	CcSEcCtD
Octreotide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000277	CcSEcCtD
Octreotide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000276	CcSEcCtD
Octreotide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000275	CcSEcCtD
Octreotide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000275	CcSEcCtD
Octreotide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000274	CcSEcCtD
Octreotide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000274	CcSEcCtD
Octreotide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000273	CcSEcCtD
Octreotide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000273	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000146	0.000455	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000146	0.000455	CbGpPWpGaD
Octreotide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000267	CcSEcCtD
Octreotide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000265	CcSEcCtD
Octreotide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000264	CcSEcCtD
Octreotide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000263	CcSEcCtD
Octreotide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000263	CcSEcCtD
Octreotide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000263	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000142	0.000441	CbGpPWpGaD
Octreotide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000262	CcSEcCtD
Octreotide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000261	CcSEcCtD
Octreotide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000259	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000139	0.000434	CbGpPWpGaD
Octreotide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000255	CcSEcCtD
Octreotide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000254	CcSEcCtD
Octreotide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000254	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000137	0.000428	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000136	0.000423	CbGpPWpGaD
Octreotide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000251	CcSEcCtD
Octreotide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000248	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000134	0.000416	CbGpPWpGaD
Octreotide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000246	CcSEcCtD
Octreotide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000245	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000132	0.00041	CbGpPWpGaD
Octreotide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000243	CcSEcCtD
Octreotide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000243	CcSEcCtD
Octreotide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000243	CcSEcCtD
Octreotide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000242	CcSEcCtD
Octreotide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000236	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000128	0.000397	CbGpPWpGaD
Octreotide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000234	CcSEcCtD
Octreotide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000234	CcSEcCtD
Octreotide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000234	CcSEcCtD
Octreotide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000233	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000125	0.000388	CbGpPWpGaD
Octreotide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000229	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000122	0.000381	CbGpPWpGaD
Octreotide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000225	CcSEcCtD
Octreotide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000224	CcSEcCtD
Octreotide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000223	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00012	0.000375	CbGpPWpGaD
Octreotide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000222	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00012	0.000372	CbGpPWpGaD
Octreotide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000221	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000119	0.000369	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000117	0.000364	CbGpPWpGaD
Octreotide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000211	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000111	0.000346	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000109	0.000341	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000108	0.000338	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000108	0.000336	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000106	0.00033	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.0001	0.000312	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.79e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.72e-05	0.000303	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.67e-05	0.000301	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.37e-05	0.000229	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.33e-05	0.000228	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.06e-05	0.00022	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.03e-05	0.000219	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.27e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.23e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.78e-05	0.00018	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.75e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.71e-05	0.000178	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.33e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.15e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.68e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.4e-05	0.000106	CbGpPWpGaD
